Components of DNA-encoded libraries

Small-molecule discovery through DNA-encoded libraries

DNA-encoded library technology has matured into a widely used platform for small-molecule discovery. Read about examples that illustrate its capabilities in this Review in the September issue.

  • Alexander A. Peterson
  • David R. Liu
Review Article



    • CRISPR-based genome editing has the potential to treat many human genetic diseases, but achieving stable, efficient and safe in vivo delivery remains a challenge. This Review assesses current delivery systems for genome editors—focusing on adeno-associated viruses and lipid nanoparticles—and highlights data from recent clinical trials. Emerging delivery systems and ongoing challenges in the field are discussed.

      • Victoria Madigan
      • Feng Zhang
      • James E. Dahlman
      Review Article
    • Advances in computational omics technologies are enabling access to the hidden diversity of natural products, and artificial intelligence approaches are facilitating key steps in harnessing the therapeutic potential of such compounds, including biological activity prediction. This article discusses synergies between these fields to effectively identify drug candidates from the plethora of molecules produced by nature, and how to address the challenges in realizing the potential of these synergies.

      • Michael W. Mullowney
      • Katherine R. Duncan
      • Marnix H. Medema
      Review Article
    • In vivo gene supplementation using adeno-associated virus (AAV) vectors holds substantial promise for a range of neurological disorders. In this Review, the authors discuss ongoing clinical trials and growing knowledge on factors that affect translational success and safety. They outline approaches to increase efficacy and reduce potential toxicity, including optimization of the AAV vector, and consider new frontiers and unmet needs in the field.

      • Qinglan Ling
      • Jessica A. Herstine
      • Steven J. Gray
      Review Article
    • Malaria case numbers are rising globally and there is a vital need for new medicines that overcome the emergence of drug resistance. This Review describes the current landscape of small-molecule antimalarial therapies and the methods used to discover them as well as perspectives on approaches to find new targets and treatments.

      • Jair L. Siqueira-Neto
      • Kathryn J. Wicht
      • Elizabeth A. Winzeler
      Review Article
    • Duchenne muscular dystrophy is an inherited muscle-wasting disease caused by mutations that disrupt production of dystrophin protein. This Review discusses the plethora of therapeutic approaches being developed to restore dystrophin function, such as exon skipping, gene replacement, cell therapy and gene editing, and highlights recent clinical approvals.

      • Thomas C. Roberts
      • Matthew J. A. Wood
      • Kay E. Davies
      Review Article

Nature Careers